Pharmaceutical group ยท Germany
Ursapharm
A group of 7 companies with 19 medicines in 4 countries.
Group structure
7 companies in 6 countries
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท Germany
A group of 7 companies with 19 medicines in 4 countries.
7 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
19 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Allergo-COMOD oogdruppels, 20 mg/mlOogdruppels, oplossing | Dinatriumcromoglicaat | Netherlands | Authorised | 1992 |
| Azelastin COMODยฎ0.5mg/mL ยท kapi za oฤi, rastvor | Azelastine | Serbia | Authorised | 2024 |
| Chlooramfenicol-POS 1%, oogzalf 10 mg/gOogzalf | Chloramphenicol | Netherlands | Authorised | 1995 |
| Dexa-POS, oogdruppels 1 mg/mlOogdruppels, oplossing | Dexamethasone | Netherlands | Authorised | 1999 |
| Dexagenta-POS, oogdruppels 1 en 5 mg/mlOogdruppels, oplossing | Dexamethasone, Gentamicin | Netherlands | Authorised | 1995 |
| Gentamicine-POS 3 mg/ml, oogdruppels, oplossingOogdruppels, oplossing | Gentamicin | Netherlands | Authorised | 1995 |
| Ofloxacine-POS 3 mg/ml, oogdruppels, oplossingOogdruppels, oplossing | Ofloxacin | Netherlands | Authorised | 2012 |
| Pollispray 1 mg/ml neusspray, oplossingNeusspray, oplossing | Azelastine | Netherlands | Authorised | 2015 |
| POLLIVALCollirio, soluzione | Azelastine | Italy | Authorised | |
| Pollival, 0,5 mg/ml oogdruppels, oplossingOogdruppels, oplossing | Azelastine | Netherlands | Authorised | 2012 |
| Pollivalยฎ1mg/ml ยท sprej za nos, rastvor | Azelastine | Serbia | Authorised | 2026 |
| POSIFORLIDUnguento oftalmico | Bibrocathol | Italy | Authorised | |
| Posiforlid 20 mg/g, oogzalfOogzalf | Bibrocathol | Netherlands | Authorised | 2022 |
| Timo-COMOD 0,25%, oogdruppels 2,5 mg/mlOogdruppels, oplossing | Timolol | Netherlands | Authorised | 1998 |
| Timo-COMOD 0,5%, oogdruppels 5 mg/mlOogdruppels, oplossing | Timolol | Netherlands | Authorised | 1998 |
| URSABCollirio, soluzione | Ofloxacin | Italy | Authorised | |
| URSAFLOG COMODCollirio, soluzione | Salicylic acid | Italy | Authorised | |
| AZELASTIN-COMOD 0.5 mg/ml EYE DROP | Azelastine | Saudi Arabia | Authorised | |
| HYLO-FRESH | Hyaluronate | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 11 | 11 | 0 | CompaniesAll medicines |
| Italy | 4 | 4 | 0 | CompaniesAll medicines |
| Serbia | 2 | 2 | 0 | CompaniesAll medicines |
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IฤO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Licence: Czech statutory open data; ARES reuse and operating terms
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.